FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the field of pharmaceutical chemistry and medicine production technology, specifically, to a method for producing acetylcholinesterase (AChE) inhibitors by the formula (VI). Method consists of two stages. At the first stage, a compound by the formula (I) is produced through the interaction of compounds characterised by structural formulas (II), (III), (IV), and (V), respectively, in the presence of methanol, followed by treating the reaction mixture consecutively with chloroform and a saturated NaHCO3 solution, with subsequent evaporation of the solvent and purification of the end product by flash chromatography using a mixture of dichloromethane/MeON solvents at a 30:1 volume ratio of the solvents, containing 0.1% wt. NH3, resulting in the end product in the form of a syrup of a pale yellow to white amorphous solid substance. At the second stage, a compound by the formula (VI) is produced through the interaction of compounds characterised by formulas (I) and (VII), respectively, wherein compound (I) is dissolved in acetone and methylated with dimethyl sulphate (1 eq.), resulting in a compound by the formula (VI) in the form of a pale yellow syrup. In the above formulas, R1 constitutes benzyl, n-propyl; R2 constitutes n-butyl, cyclohexyl; n = 1, 2. The invention also relates to an acetylcholinesterase (AChE) inhibitor produced by the method.
EFFECT: proposed method allows producing new acetylcholinesterase (AChE) inhibitors.
, ,
2 cl, 65 dwg, 6 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING A NEW AMINO ACID-BASED DERIVATIVE AND AN ACETYLCHOLINESTERASE INHIBITOR (ACHE) BASED ON IT | 2021 |
|
RU2774827C1 |
METHOD FOR SYNTHESIS OF 2-CARBOXY-N,N,N-TRIMETHYLETHANAMINIUM DERIVATIVE | 2021 |
|
RU2786884C2 |
GCN2 INHIBITORS AND THEIR USE | 2019 |
|
RU2811408C2 |
BENZO-DERIVATIVES WITH SIX-MEMBERED RING AS DPP-4 INHIBITOR AND USE THEREOF | 2015 |
|
RU2702644C2 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2589878C2 |
PD-L1 ANTAGONIST COMPOUND | 2020 |
|
RU2823231C1 |
GCN2 INHIBITORS AND THEIR USE | 2019 |
|
RU2811403C2 |
AMINE DERIVATIVES OF DIARYLPYRIMIDINES AS INHIBITORS OF NITRIC OXIDE AND INTERLEUKIN 6 RELEASE | 2022 |
|
RU2812550C1 |
METHOD OF PRODUCING LENALIDOMIDE AND AN INTERMEDIATE FOR PRODUCTION THEREOF | 2020 |
|
RU2730858C1 |
Authors
Dates
2022-09-09—Published
2021-06-01—Filed